The efficacy of autologous blood donation in coronary surgery - A retrospective analysis;Die Effektivitat der Eigenblutspende in der Koronarchirurgie - Eine retrospektive Analyse

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 32, Issue 5, 1997, Pages 291-297

  Kulka, P J ^a,b   Tryba, M ^a   Welsch, P ^a   Zenz, M ^a  

^a Fachbereich Mathematik und Informatik   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

coronary artery bypass surgery; homologous blood transfusion; transfusion; transfusion requirements

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD DONOR; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS SURGERY; FEMALE; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; BLOOD; BLOOD AUTOTRANSFUSION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; HEART MUSCLE REVASCULARIZATION; HEMOGLOBIN DETERMINATION; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; SURVIVAL;

AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION, AUTOLOGOUS; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; HEMOGLOBINOMETRY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0031132372     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995057     Document Type: Article

References (39)

1. Biesma DH, Marx JJ, Kraaijenhagen RJ, Franke W, Messinger D, von de Wiel A: Lower homologous blood requirements in autologous blood donors after treatment with recombinant human erythropoietin. Lancet 1994;344:367-370
2. Delphin E, Jordan D, Dominguez C: Gender related transfusion requirements during cardiac surgery. Anesth. Analg. 1995;80: SCA 134
3. DelRossi A, Cernaianu AC, Vertrees RA: Platelet-rich plasma reduces postoperative blood loss after cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 1990;100:281-286
4. Dietrich W: Shed mediastinal blood retransfusion should be used routinely in cardiac surgery. Pro.J. Cardiothorac. Vasc. Anesth. 1995;9:95-99
5. Dietrich W, Barankay A, Dilthey G, Richter JA: Autotransfusion and hemoseparation in cardiac surgery. What can be saved in cardiac reoperations and operations of thoracic aneurysma repair? Thorac. Cardiovasc. Surg. 1989;37:84-88
6. Dzik WH, Fleisher AG, Ciavarella D, Karlson KJ, Reed GE, Berger RL: Safety and efficacy of autologous blood donation before elective aortic valve operation. Ann. Thorac. Surg. 1992;54: 1177-1180
7. Gombotz H, Kulier A: Reduktion des Fremdblutverbrauchs in der operativen Medizin. Anaesthesist 1995;44:191-218
8. Goodnough LT, Brittenham GM: Limitation of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs. J. Lab. Med. 1990;115:28-35
9. Goodnough LT, Johnston MFM, Toy PTCY: The variability of transfusion practice in coronary artery bypass surgery. JAMA 1991;265:86-90
10. Kasper SM, Dahlmann H, Gerlich W: Zur Bedeutung der autologen Bluttransfusion in der Bundesrepublik Deutschland. Anaesthesist 1991;40:594-601
11. Kasper SM, Kiencke P, Lynch J, Beiten D: Gegenwärtiger Stand der autologen Bluttransfusion in der Bundesrepublik Deutschland. Anaesthesist 1995;44:230-241
12. Kubanek B, Cardoso M, Glück D, Körner K: Risiko einer Infektionsübertragung durch Blutkomponenten. Infusionsther. Transfusionsmed. 1993;20:54-59
13. Lavee J, Martinowitz U, Mohr R: The effect of transfusion of fresh whole blood versus platelet concentrates after cardiac operations - a scanning electron microscope study of platelet aggregation on extracellular matrix. J. Thorac. Cardiovasc. Surg. 1989;97:204-212
14. Mazer CD: Con: Shed mediastinal blood should not be reinfused after cardiac surgery. J. Cardiothorac. Vasc. Anesth. 1995;9:100-102
15. McCarthy PM, Popovsky MA, Schaff HV: Effect of blood conservation efforts in cardiac operations at the Mayo Clinic. Mayo Clin. Proc. 1988;63:225-229
16. Miholic J, Hudec M, Domanig E: Risk factors for severe bacterial infections after valve replacement and aortocoronary bypass operations: analysis of 246 cases by logistic regression. Ann. Thorac. Surg. 1985;40:224-229
17. Mohr R, Martinowitz U, Lavee J: The hemostatic effect of transfusing fresh whole blood versus platelet concentrates after cardiac operations. J. Thorac. Cardiovasc. Surg. 1988;96:530-534
18. Niemer M, Nemes C, Lundsgaard-Hansen P, Blauhut B: Datenbuch Intensivmedizin, 3.Auflage, Gustav Fischer Verlag, Stuttgart, 1992
19. Osswald PM, Lorentz A: Präoperative Eigenblutspende. In: Ahnefeld FW, Bergmann H, Kilian J, Kubanek B und Weissauer W: Fremdblutsparende Maßnahmen. Springer Verlag, Berlin, 1993
20. Ottino G, De-Paulis R, Pansini S: Major sternal wound infection after open-heart surgery: a multivariate analysis of risk factors in 2579 consecutive operative procedures. Ann. Thorac. Surg. 1987;44:173-179
21. Ovrum E, Am Holen E, Lindstein-Ringdal MA: Coronary artery bypass surgery with minimal use of homologous blood. Effects of a simple and inexpensive blood conservation programme. Eur. J. Cardiothorac. Surg. 1990;4:644-648
22. Parrot D, Lancon JP, Merle JP, Rerolle A, Bernard A, Obadia JF, Caillard B: Blood salvage in cardiac surgery. J. Cardiothorac. Vasc. Anesth. 1991;5:454-456
23. Robblee J: Graft occlusion following administration of tranexamic acid. Anesth. Analg. 1995;80:141
24. Roggendorf M: Bedeutung der HCV-Infektion für die posttransfusionelle Hepatitis. Infusionsther. Transfusionsmed. 1994;21: 12-18
25. Royston D: High-dose aprotinin therapy: a review of the first five years' experience. J. Cardiothorac. Vasc. Anesth. 1992;6:76-100
26. Sherman MM, Dobnik DB, Dennis RC, Berger RL: Autologous blood transfusion during cardiopulmonary bypass. Chest 1976; 70:592-595
27. Shore-Lesserson L, Reich DL, DePerio M, Silvay G: Autologous platelet-rich plasmapheresis: risk versus benefit in repeat cardiac operation. Anesth. Analg. 1995;81:229-235
28. Sibrowski W, Penner M, Kühnl P: Transfusionsbedingte Virus-infektionen: Wie groß ist das Restrisiko? Infusionsther. Transfusionsmed. 1993;20:4-9
29. Southern EP, Huo MH, Mahte JR, Keggi KJ: Unwashed wound drainage blood. What are we giving our patients? Clin. Orthop. 1995;320:235-246
30. Speekenbrink RGH, Vonk ABA, Wiuldevuur CRH, Eijsmann L: Hemostatic efficacy of dipyridamol, tranexamic acid, and aprotinin in coronary bypass grafting. Ann. Thorac. Surg. 1995;59: 438-442
31. Spiess BD: Pro: Autologous blood should be available for elective cardiac surgery. J. Cardiothorac. Vasc. Anesth. 1994;8:231-237
32. Stehling L: Trends in transfusion therapy. Anesthesiol. Clin. North Am. 1990;8:519-532
33. Surgenor DM, Wallace EL, Churchill WH: Red cell infusions in coronary artery bypass surgery. Transfusion 1992;32:458-464
34. Tryba M: Epoetin alpha plus autologous blood donation and normovolemic hemodilution in patients scheduled for orthopedic or vascular surgery. Semin. Hematol. 1996;33:34-38
35. Tyson GS, Spainhour V, Savitt MA, Ferguson TB, Wolfe WG: Blood conservation in cardiac surgery. Preliminary results with an institutional commitment. Ann. Surg. 1989;209:736-742
36. Utley JR, Moores WY, Stephens DB: Blood conservations techniques. Ann. Thorac. Surg. 1981;31:482-490
37. von Borman B, Friedrich M: Hämodilution. Ahnefeld FW, Bergmann H, Kilian J, Kubanek B und Weissauer W: Fremdblutsparende Methoden. Springer Verlag, Berlin, 1993:161-171
38. von Bormann B, Boldt J, Kling D, Weidler B, Scheld HH, Hempelmann G: Kombinierte Autotransfusion in der Herzchirurgie. Anwendung der akuten normovolämische Hämodilution bei koronarer Herzkrankheit. Dtsch. Med. Wochenschr. 1987;112: 1887-1892
39. Wittig M, Osswald PM, Lorentz A, Jani L: Kurze Abnahmeintervalle bei der präoperativen Eigenblutspende im Konzept der autologen Transfusion. Anaesthesist 1994;43:9-15